Skip to search formSkip to main contentSkip to account menu

procarbazine/thalidomide

Known as: PCB/THAL 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2015
2015
BACKGROUND Hydroxyurea is a cytotoxic and myelosuppressive drug that has been used during recent years in the treatment of… 
Highly Cited
2014
Highly Cited
2014
Multiple myeloma (MM) accounts for 1% of all types of cancer and for 2% of all cancer deaths. These numbers are approximately 13… 
2013
2013
INTRODUCTION hemoglobinopathies constitute a major health problem worldwide. These disorders are characterized by a clinical and… 
Review
2007
Review
2007
This paper summarizes the results on the epidemiology and molecular basis of thalassemias and other hemoglobinopathies in the… 
2005
2005
The palliation of patients with megaesophagus secondary to achalasia of the cardia presents significant challenges to the surgeon… 
2004
2004
Sight threatening changes in the retina are a well-recognized complication of sickle cell disease (SCD). However they usually… 
2004
2004
(p = 0.001). Earlier it has been demons t ra ted t h a t the chromosome breaks produced by 5-ftnorodeoxyuridine can be… 
1987
1987
In a recent study, it was reported that thalidomide may suppress mucosal, cutaneous and articular manifestations in the major i… 
1987
1987
The purpose of this study was to ascertain whether thalassemia heterozygotes (α thal) who have sickle cell anemia (SCA) suffer… 
1969
1969
Thalidomide treatment of patients suffering from leprosy reaction (LR ) was introduced in 1964 (3). This thcrapy has a striking…